Novartis
NVS
NVS
761 hedge funds and large institutions have $18.7B invested in Novartis in 2013 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 282 increasing their positions, 294 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.03% less ownership
Funds ownership: 9.93% → 9.91% (-0.03%)
0% less funds holding
Funds holding: 763 → 761 (-2)
4% less repeat investments, than reductions
Existing positions increased: 282 | Existing positions reduced: 294
Holders
761
Holding in Top 10
55
Calls
$102M
Puts
$79.7M
Top Buyers
| 1 | +$88.1M | |
| 2 | +$67M | |
| 3 | +$46.8M | |
| 4 |
Renaissance Technologies
New York
|
+$32.5M |
| 5 |
Bank of New York Mellon
New York
|
+$24.5M |
Top Sellers
| 1 | -$148M | |
| 2 | -$52.6M | |
| 3 | -$49.5M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$48.1M |
| 5 |
Two Sigma Investments
New York
|
-$30.8M |